Clinical case of a patient with AADC deficiency of L-aromatic amino acid decarboxylase: diagnostic route and therapeutic options
Authors:
- Евгения Владимировна УвакинаЕУЕвгения Владимировна Увакина
- Людмила Михайловна КузенковаЛКЛюдмила Михайловна Кузенкова
- Dmitry I. GukosyanDGDmitry I. Gukosyan
- София Георгиевна ПоповичСПСофия Георгиевна Попович
- Татьяна Владимировна ПодклетноваТПТатьяна Владимировна Подклетнова
- Anastasia A. LyalinaALAnastasia A. Lyalina
- Александр Алексеевич ПушковАПАлександр Алексеевич Пушков
- Kirill V. SavostyanovKSKirill V. Savostyanov
- Дарья Сергеевна НиколенкоДНДарья Сергеевна Николенко
Open Access
- 31 January 2025
- journal article
- Published by National Medical Research Center for Childrens Health in L.O. Badalyan Neurological Journal
- Vol. 5 (4) , 225-232
Abstract
L-aromatic amino acid decarboxylase deficiency (AADC) is a rare autosomal recessive neurometabolic disease characterized by impaired biosynthesis of neurotransmitters and manifested by disorders of movement and autonomic regulation. In the article there is discussed the diagnostic path and treatment options for a 7-year patient with severe AADC deficiency. Combination of severe neurological disorders (muscular hypotension, dystonia, hyperkinesis, oculogyric crises) and autonomic disorders (increased sweating, hypersalivation, thermoregulation disorders, nasal congestion, dyspepsia, etc.) is clearly demonstrated to require the detection of 3-O-methyldopa in dried blood spots to exclude AADC deficiency. Given the emergence of gene therapy, which is available to patients with a confirmed diagnosis of AADC deficiency in Russia within the criteria of the Circle of Kindness Foundation, it is necessary to popularize information about L-aromatic amino acid decarboxylase deficiency in the general medical community, to improve the prognosis and quality of life in AADC patients.Keywords
This publication has 12 references indexed in Scilit:
- Aromatic l‐amino acid decarboxylase deficiency in TaiwanJIMD Reports, 2023
- Prevalence of DDC genotypes in patients with aromatic L-amino acid decarboxylase (AADC) deficiency and in silico prediction of structural protein changesMolecular Genetics and Metabolism, 2023
- Corrigendum to “ Biochemical diagnosis of aromatic-L-amino acid decarboxylase deficiency (AADCD) by assay of AADC activity in plasma using liquid chromatography/tandem mass spectrometry” [32/100888 (2022) page 1–4].Molecular Genetics and Metabolism Reports, 2022
- Spectrum of DDC variants causing aromatic l-amino acid decarboxylase (AADC) deficiency and pathogenicity interpretation using ACMG-AMP/ACGS recommendationsMolecular Genetics and Metabolism, 2022
- Burden and severity of disease of aromatic L-amino acid decarboxylase deficiency: a systematic literature reviewCurrent Medical Research and Opinion, 2022
- AADC deficiency from infancy to adulthood: Symptoms and developmental outcome in an international cohort of 63 patientsJournal of Inherited Metabolic Disease, 2020
- Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlookMolecular Genetics and Metabolism, 2019
- Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiencyOrphanet Journal of Rare Diseases, 2017
- Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiencyNeurology, 2010
- Aromatic amino acid decarboxylase deficiency in twinsJournal of Inherited Metabolic Disease, 1990